Sensex Up Over 500 Points, Nifty Above 17,600; Divi's Labs, NTPC Top Gainers

Merck and company's partner Ridgeback Biotherapeutics said its experimental antiviral drug molnupiravir could halve chances of dying or being hospitalised; Divi's Laboratories makes the main...